These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1736291)

  • 1. Tamoxifen prevents induction of hepatic neoplasia by zeranol, an estrogenic food contaminant.
    Coe JE; Ishak KG; Ward JM; Ross MJ
    Proc Natl Acad Sci U S A; 1992 Feb; 89(3):1085-9. PubMed ID: 1736291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-induced hepatic toxicity and hepatic cancer: differences between two closely related hamster species.
    Coe JE; Ishak KG; Ross MJ
    Liver; 1998 Oct; 18(5):343-51. PubMed ID: 9831364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen inhibits estrogen-induced hepatic injury in hamsters.
    Coe JE; Ross MJ
    Endocrinology; 1988 Jan; 122(1):137-44. PubMed ID: 3335202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zeranol--a 'nature-identical' oestrogen?
    Lindsay DG
    Food Chem Toxicol; 1985 Aug; 23(8):767-74. PubMed ID: 2931335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prepubertal zeranol exposure on estrogen target organs and N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
    Yuri T; Nikaido Y; Shimano N; Uehara N; Shikata N; Tsubura A
    In Vivo; 2004; 18(6):755-61. PubMed ID: 15646816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral zeranol shortens the prolonged bleeding time of uremic rats.
    Zoja C; Viganò G; Corna D; Salmona M; Remuzzi G; Garattini S
    Kidney Int; 1990 Jul; 38(1):96-100. PubMed ID: 2385090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells.
    Yuri T; Tsukamoto R; Miki K; Uehara N; Matsuoka Y; Tsubura A
    Oncol Rep; 2006 Dec; 16(6):1307-12. PubMed ID: 17089054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mycoestrogen zeranol at high dosage antagonizes transient receptor potential channel activities in 3T3 L1 cells.
    Li Q; Tan YQ; Cheung KK; Chiu-Leung LC; Leung LK
    Toxicol Lett; 2021 Jun; 344():18-25. PubMed ID: 33689779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol metabolites of zeranol and 17β-estradiol: a comparative in vitro study on the induction of oxidative DNA damage and methylation by catechol-O-methyltransferase.
    Fleck SC; Hildebrand AA; Pfeiffer E; Metzler M
    Toxicol Lett; 2012 Apr; 210(1):9-14. PubMed ID: 22285433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogenic potencies of resorcylic acid lactones and 17 beta-estradiol in female rats.
    Everett DJ; Perry CJ; Scott KA; Martin BW; Terry MK
    J Toxicol Environ Health; 1987; 20(4):435-43. PubMed ID: 2951527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of MCF-10A human breast epithelial cells by zeranol and estradiol-17beta.
    Liu S; Lin YC
    Breast J; 2004; 10(6):514-21. PubMed ID: 15569208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zeranol: doping offence or mycotoxin? A case-related study.
    Thevis M; Fusshöller G; Schänzer W
    Drug Test Anal; 2011; 3(11-12):777-83. PubMed ID: 22095651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of estrogens as promoters of hepatic neoplasia.
    Wanless IR; Medline A
    Lab Invest; 1982 Mar; 46(3):313-20. PubMed ID: 6278220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of in utero exposure to nonsteroidal estrogens on mouse testis.
    Pérez-Martínez C; Ferreras-Estrada MC; García-Iglesias MJ; Bravo-Moral AM; Espinosa-Alvarez J; Escudero-Diez A
    Can J Vet Res; 1997 Apr; 61(2):94-8. PubMed ID: 9114959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic hydroxylation and catechol formation: a novel metabolic pathway of the growth promotor zeranol.
    Hildebrand A; Pfeiffer E; Metzler M
    Toxicol Lett; 2010 Feb; 192(3):379-86. PubMed ID: 19931366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogenic activity of zearalenone and zearalanol in the neonatal rat uterus.
    Sheehan DM; Branham WS; Medlock KL; Shanmugasundaram ER
    Teratology; 1984 Jun; 29(3):383-92. PubMed ID: 6235618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The non-steroidal mycoestrogen zeranol suppresses luteinizing hormone secretion from the anterior pituitary of cattle via the estradiol receptor GPR30 in a rapid, non-genomic manner.
    Nakamura U; Rudolf FO; Pandey K; Kadokawa H
    Anim Reprod Sci; 2015 May; 156():118-27. PubMed ID: 25824341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zeranol stimulates proliferation and aromatase activation in human breast preadipocytes.
    Zhong S; Liu S; Chen S; Lin H; Wang W; Qin X
    Mol Med Rep; 2016 Jul; 14(1):1014-8. PubMed ID: 27220457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of zearalenone and zearalenols to their major glucuronide metabolites reduces estrogenic activity.
    Frizzell C; Uhlig S; Miles CO; Verhaegen S; Elliott CT; Eriksen GS; Sørlie M; Ropstad E; Connolly L
    Toxicol In Vitro; 2015 Apr; 29(3):575-81. PubMed ID: 25645597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carcinogenic potential of estrogens used in breeding].
    Rico AG
    Food Addit Contam; 1984; 1(2):95-100. PubMed ID: 6536538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.